The minimally invasive surgery market is undergoing significant expansion as healthcare providers and patients increasingly favor procedures associated with smaller incisions, shorter hospital stays, reduced complications, and faster recovery. According to Grand View Research, the market was valued at USD 518.3 billion in 2025 and is projected to grow from USD 553.3 billion in 2026 to USD 946.5 billion by 2033, registering a CAGR of 8.0% from 2026 to 2033. Technological advancements, a growing geriatric population, and the increasing burden of chronic diseases are contributing to this growth.

Download a free sample copy of the Minimally Invasive Surgery market report to understand detailed coverage and inclusions in the final report

Rising Surgical Volumes Create Stronger Demand for MIS

Increasing surgical volumes are a major factor supporting market development. Minimally invasive approaches have become preferred for many procedures because of their safety and recovery benefits. The adoption of these techniques is supported by clinical advantages including shorter hospital stays, fewer complications, decreased recovery time, reduced blood loss, and smaller incisions.

The growing prevalence of chronic diseases and the expanding geriatric population are also increasing the need for surgical interventions. For elderly patients, minimizing surgical trauma and recovery time can be particularly important. Laparoscopic and robotic-assisted approaches are being used across specialties to address these changing requirements.

Gynecological Surgery Maintains the Leading Specialty Position

Among surgical specialties, gynecological surgery held the largest market share of 33.4% in 2025. Procedures such as hysterectomy, myomectomy, and endometriosis treatment contribute significantly to demand. The segment is projected to register a CAGR of 7.74% during the forecast period.

The bariatric surgery segment is also expected to experience significant growth, with a CAGR of 8.88% from 2025 to 2033. Increasing obesity prevalence and advances in minimally invasive techniques are supporting demand for procedures that offer quicker recovery and reduced complications. The integration of bariatric procedures with weight-loss medications such as GLP-1 agonists is also identified as a factor supporting treatment outcomes and market expansion.

Robotic-Assisted Surgery Pushes Precision Forward

Robotic-assisted surgery represented the leading method category, accounting for 33.9% of revenue share in 2025. The segment is expected to grow at a CAGR of 8.98% over the forecast period. Hospitals are increasingly adopting robotic systems for complex procedures across specialties such as urology, gynecology, and cardiothoracic surgery.

Technological development is extending beyond robotics. Intraoperative imaging, navigation systems, augmented reality, computational planning, advanced visualization, and AI-based technologies are enhancing precision and decision-making. AI-powered systems can assist with surgical planning, instrument tracking, real-time visualization, and intraoperative decision-making.

Hospitals Remain the Primary End-Use Setting

Hospitals held the largest end-use share at 55.7% in 2025 and are expected to register a CAGR of 7.78% during the forecast period. Their advanced infrastructure, skilled surgical teams, and ability to perform complex procedures contribute to this position.

At the same time, ambulatory surgical centers are becoming increasingly important. The ASC segment is expected to grow at a CAGR of 8.29% during the forecast period. Lower costs, faster scheduling, and same-day discharge make these facilities attractive for selected minimally invasive procedures. Improvements in laparoscopy, imaging, and robotics are also making more advanced procedures feasible in outpatient settings.

AI and Robotics Open New Paths for Surgical Innovation

Artificial intelligence and machine learning represent important opportunities for the market. AI-enabled systems can analyze large volumes of patient and procedural data to support surgical planning, guidance, image recognition, and workflow optimization. Machine learning can also be incorporated into robotic-assisted platforms to improve precision and provide predictive support.

The market page highlights an AI-guided solo surgery case in which an AI-powered camera tracked surgical instruments and automatically adjusted its angle. Such developments demonstrate how automation could improve efficiency and reduce the need for additional assistance during selected procedures.

Other technologies, including 3D bioprinting and soft robotics, are also creating new possibilities. Robotic-assisted bioprinting can support precise placement of living cells and biomaterials, while soft robotic platforms can provide flexible access to complex anatomical areas.

Training and Equipment Costs Remain Important Challenges

Despite strong adoption potential, the market faces barriers. A shortage of adequately trained surgeons can limit implementation because minimally invasive procedures often require specialized technical expertise and extensive training. The learning curve can be particularly challenging for smaller healthcare facilities and cost-sensitive markets.

Advanced robotic, laparoscopic, and imaging systems also require substantial acquisition, maintenance, servicing, and upgrading expenditures. These costs can place financial pressure on hospitals and ambulatory surgical centers and may slow adoption where healthcare resources are constrained.

Competitive Landscape Centers on Advanced Surgical Platforms

Established players are investing in robotic-assisted surgery, laparoscopy, endoscopy, energy devices, visualization systems, AI-assisted surgery, advanced imaging, and digital operating room integration. Emerging companies are emphasizing cost-effective platforms, modular systems, portability, workflow optimization, and flexible purchasing models.

FAQs

What trends are shaping the minimally invasive surgery market?

Key trends include increasing use of robotic-assisted surgery, AI and machine learning integration, advanced visualization, intraoperative imaging, navigation systems, soft robotics, 3D bioprinting, and the movement of selected procedures toward ambulatory surgical centers.

What challenges are affecting the minimally invasive surgery market?

The major challenges identified include shortages of adequately trained surgeons, the learning curve associated with sophisticated procedures, and the substantial acquisition, maintenance, servicing, and upgrading costs associated with advanced surgical equipment.

Key Minimally Invasive Surgery Companies:

Medtronic plc
Intuitive Surgical
CMR Surgical
Smith & Nephew plc

Explore the full list of profiled companies operating in this market with recent strategic initiatives

About us:

Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.

Minimally Invasive Surgery Demand Expands Beyond Traditional Hospital Settings

The global minimally invasive surgery market size was valued at USD 518.3 billion in 2025 and is projected to grow from USD 553.3 billion in 2026 to USD 946.5B